Biomedical research at mayo clinic: A tradition of collaboration and a vision for year 2000 and beyond

TY - JOUR

T1 - Biomedical research at mayo clinic

T2 - A tradition of collaboration and a vision for year 2000 and beyond

AU - Burnett, Jr

N1 - Funding Information: The new CPOR represents the key facilitator in Mayo's strategic plan for future clinical research. This new facility is designed to enhance the environment and infrastructure for patient-oriented research. It responds to the increasing complexity of patient-oriented research that requires a more integrative infrastructure for clinical investigation and a mechanism to educate future clinical scientists in the modern methods of human investigation. CPOR's aim is to ensure that Mayo Clinic remains a premier institution for biomedical research by assisting the researcher with all phases of patient-oriented research, from design to implementation to publication of clinical investigation. 7 CPOR brings into a single physical location the infrastructure needed to conduct successful patient-oriented research. Indeed, it exists in geographic partnership with the NIH funded General Clinical Research Center, which has a long and distinguished history of human investigation. The establishment of CPOR therefore represents Mayo's vision of the final step in successful research-the translation of fundamental advances in the basic sciences and diseaseoriented applied research in the laboratory to the patient and to human populations. Mayo's commitment to clinical research was recently recognized when the NIH awarded to Mayo a grant to establish a training program in clinical investigation. Funding Information: Mayo is now engaged in developing a strategic plan for research focused on the spirit of discovery and translation from the bench to the bedside to populations. This strategic vision also targets the need for harnessing the new technologies that are a product of new biology. A hallmark of this process has been a continuing commitment to excellence. Indeed, the recent award to Mayo of a major multimillion-dollar grant from the Howard Hughes Medical Institute (HHMI) to support research infrastructure underscores the recognition of Mayo Clinic as a medical institution committed to cutting-edge investigation. The HHMI grant in part recognized Mayo's unique position as an institution that bridges basic science and clinical medicine and uses its strong patient base as a mechanism to understand human disease. The HHMI support in 3 specific areas—gene discovery in cancer, a vector production facility for gene therapy, and support for the new Center for Patient-Oriented Research (CPOR)—acknowledges Mayo's commitment to translational research.

PY - 2000

Y1 - 2000

UR - http://www.scopus.com/inward/record.url?scp=0034126306&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034126306&partnerID=8YFLogxK

U2 - 10.4065/75.4.337

DO - 10.4065/75.4.337

M3 - Editorial

C2 - 10761485

AN - SCOPUS:0034126306

SN - 0025-6196

VL - 75

SP - 337

EP - 339

JO - Mayo Clinic proceedings

JF - Mayo Clinic proceedings

IS - 4

ER -